To Treat Frontotemporal Dementia, Treat the Brain’s Immune Cells
Though FTD is not as well known as Alzheimer’s disease, it’s the second most common cause of dementia in people under 65, and there’s currently no treatment.
University of California San Francisco
Give to UCSF
Immune Cells in Spinal Fluid of Multiple Sclerosis Patients Identified as Likely Disease Drivers
New UCSF research sheds light on how immune system B cells that infiltrate the central nervous system may drive multiple sclerosis.
Female Chromosomes Offer Resilience to Alzheimer’s
UCSF scientists now have evidence from research that women with Alzheimer’s live longer than men with the disease because they have genetic protection from the ravages of the disease.
Non-Invasive Nerve Stimulation Boosts Learning of Foreign Language Sounds
New research by neuroscientists at the University of Pittsburgh and UC San Francisco revealed that a simple, earbud-like device developed at UCSF that imperceptibly stimulates a key nerve leading to the brain could significantly improve the wearer’s ability to learn the sounds of a new language.
Drug Prevents Multiple Sclerosis Relapses in Phase 3 Trial
A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS) – the most common form of the illness, in which symptoms wax and wane.
UCSF Medical Center Ranks Among Nation’s 10 Best Hospitals for 2020-21
UCSF Medical Center has been recognized as one of the nation’s finest hospitals in the U.S. News & World Report 2020-2021 Best Hospitals survey, ranking among the top 10 hospitals nationwide for the 22nd year.
We Thought It Was Just a Respiratory Virus
UCSF researchers are taking a closer look at COVID-19’s dizzying array of symptoms to get at the disease’s root causes.
Older Adults Who Can Really Smell the Roses May Face Lower Likelihood of Dementia
Seniors who can identify smells like roses, turpentine, paint-thinner and lemons, and have retained their senses of hearing, vision and touch, may have half the risk of developing dementia as their peers with marked sensory decline, according to a new UCSF study.
To Let Neurons Talk, Immune Cells Clear Paths Through Brain’s ‘Scaffolding’
A new study by UCSF researchers identified a surprising way that the brain’s immune cells help to form new memories.
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
Under a new agreement, Celgene will further invest in the RAN’s state-of-the-art antibody engineering program to expand target discovery from oncology and immunology to include neurology.
UCSF Benioff Children’s Hospitals Rank Among the Nation’s Best for 10 Specialties in 2020-2021 U.S. News & World Report
The annual U.S. News rankings serve as a guide of hospitals nationwide that excel in treating children with the most challenging diagnoses.
FDA Approves Video Game Based on UCSF Brain Research as ADHD Therapy for Kids
The FDA has approved the first video game therapeutic as a treatment for attention deficit hyperactivity disorder (ADHD) in children, based on research by UCSF’s Adam Gazzaley, MD, PhD.
Disrupted Circadian Rhythms Linked to Later Parkinson's Diagnosis
Older men who have a weak or irregular circadian rhythm guiding their daily cycles of rest and activity are more likely to later develop Parkinson’s disease, according to a new study by scientists at the UCSF Weill Institute for Neurosciences who analyzed 11 years of data for nearly 3,000 independently living older men.
